Complete Guide to Gentamicin in older adults Pharmacokinetics
Overview
Gentamicin in older adults is a Aminoglycoside antibiotic used in the Infectious diseases / Geriatrics therapeutic area. It is indicated for Gram-negative bacterial infections in older adults. Interactive gentamicin population PK simulator for older adults showing the independent impact of frailty, creatinine clearance, and lean body weight on exposure.
Mechanism of Action
Gentamicin in older adults exerts its pharmacological effect by targeting 30S ribosomal subunit. As a Aminoglycoside antibiotic, it modulates this target to achieve therapeutic efficacy in Gram-negative bacterial infections in older adults. Understanding the target engagement is critical for interpreting the pharmacokinetic-pharmacodynamic (PK/PD) relationship and optimizing dosing regimens.
Key Pharmacokinetic Parameters
The following parameters are derived from published One-compartment population PK models for Gentamicin in older adults:
| Parameter | Value |
|---|---|
| V L | 14.6 |
| CL mL min | 102 |
| V equation | 14.6*(LBW/53) |
| CL equation | 102*(CrCL/45.2)*0.876^FRAIL |
| BSV V CV pct | 10.4 |
| BSV CL CV pct | 20.5 |
| frailty definition | REFS >= 8 |
Parameters represent typical population estimates from published literature. Individual values may vary.
Dosing & Administration
Gentamicin in older adults is administered via the Intravenous route. Intravenous administration provides 100% bioavailability and allows precise control of drug exposure. Infusion duration and rate can significantly impact peak concentrations.
Dosing recommendations should always follow approved prescribing information. The interactive simulator allows you to explore different dosing scenarios and their impact on drug exposure metrics such as AUC, Cmax, and Ctrough.
Clinical Considerations
In the Infectious diseases / Geriatrics therapeutic area, for the treatment of Gram-negative bacterial infections in older adults, understanding the pharmacokinetics of Gentamicin in older adults is essential for dose optimization and therapeutic drug monitoring. Key clinical factors that may affect Gentamicin in older adults pharmacokinetics include:
- •Body weight and body composition
- •Renal and hepatic function
- •Drug-drug interactions and concomitant medications
- •Age, sex, and genetic polymorphisms
Interactive Gentamicin in older adults PK Simulator
Explore Gentamicin in older adults pharmacokinetics interactively. Adjust doses, dosing intervals, and patient covariates to visualize concentration-time profiles in real time.
Frequently Asked Questions
What is the half-life of Gentamicin in older adults?
The elimination half-life of Gentamicin in older adults depends on patient-specific factors. Use our interactive Gentamicin in older adults PK simulator to explore concentration-time profiles and estimate half-life under different dosing scenarios.
How is Gentamicin in older adults administered?
Gentamicin in older adults is administered via the Intravenous route. It is indicated for Gram-negative bacterial infections in older adults. As a Aminoglycoside antibiotic, dosing regimens should follow approved prescribing information and clinical guidelines.
What are the key PK parameters of Gentamicin in older adults?
Key pharmacokinetic parameters for Gentamicin in older adults include clearance (CL), volume of distribution (Vd), and elimination half-life. See the PK Parameters section above for specific values from published models.
Can I simulate Gentamicin in older adults dosing scenarios for free?
Yes! PKPDBuilder offers a completely free, interactive Gentamicin in older adults PK simulator based on published pharmacometric models. No login required. Use it to explore different doses, dosing intervals, and patient covariates.
⚠️ Disclaimer
This guide is for research and educational purposes only. It is not intended for clinical decision-making or patient dosing. Parameters are derived from published literature and represent population estimates. Always consult approved prescribing information for clinical use.